As a pioneer and the undisputed global leader in the field of antifungal drug discovery, Creative Biolabs is fully competent and dedicated to assisting our clients with our one-stop antifungal drug discovery platform. With decades of experience, we are confident in offering the best services to totally meet your project requirements and budgets.
One-Stop Antifungal Drug Discovery
Fungi are simple eukaryotic organisms that are ubiquitous in nature and essential for recycling of nutrients contained in organic matter. Fungal diseases, ranging from cutaneous and superficial via subcutaneous complicated forms to systemic fatal forms, are caused by colonization, proliferation, and sporulation of fungi in tissues or body fluids. In general, fungal diseases can be classified into two types: opportunistic fungal infections and primary fungal infections. Opportunistic fungal infections are developed mainly in immunocompromised hosts while primary fungal infections are in immunocompetent hosts. Along with over a decade of rich experience in providing excellent custom services for antifungal drug discovery, Creative Biolabs has built the wonderful one-stop antifungal drug discovery platform against various potential targets. From the target identification to the final IND-Enabling, our complete procedure has the capability to enable you to free up your time for core work and project. The fungal cytological profiling (FCP) is also a rapid and powerful approach to identify the cellular pathway affected by antifungal molecules.
Features of Antifungal Drug Discovery Platform
Potential Targets
Fungal Diseases
As a forward-looking research institute as well as a leading custom service provider in the field of antifungal drug discovery, Creative Biolabs is always dedicated to assisting our clients with the most satisfactory antifungal-related services. If you are interested in our services, please do not hesitate to contact us for more details.
For Research Use Only.
